Երկիր: Ավստրալիա
Լեզու: անգլերեն
Աղբյուրը: Department of Health (Therapeutic Goods Administration)
normal immunoglobulin, Quantity: 50 mg/mL
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
normal immunoglobulin
Injection, intravenous infusion
Excipient Ingredients: sodium hydroxide; glycine; water for injections; dilute hydrochloric acid
Intravenous Infusion
100mL/5g/vial
(S4) Prescription Only Medicine
Replacement therapy in. * Primary Immunodeficiency Diseases. * Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. Immunomodulation. * Idiopathic thrombocytopenic purpura, in adults or children at high risk of bleeding or prior to surgery to correct the platelet count.. * Guillain Barre syndrome. * Kawasaki disease.
Visual Identification: Solution for infusion. The solution is clear to slightly opalescent and colourless to pale yellow 100 ml of solution in a vial.; Container Type: Vial; Container Material: Glass Type II Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2011-02-16